ProCE Banner Activity

Considerations for Relapsed/Refractory Myeloma: What I Do in My Practice

Clinical Thought
Gain practical insights for your care of patients with relapsed/refractory myeloma

Released: January 31, 2020

Expiration: January 29, 2021

Share

Faculty

Elisabet E. Manasanch

Elisabet E. Manasanch, MD

Leader, Early Myeloma Program
Director, Myeloma Tissue Bank
Tenured Associate Professor
University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Amgen, Inc.

Celgene

Janssen administered by Scientific Affairs

Oncopeptides

Faculty Disclosure

Primary Author

Elisabet E. Manasanch, MD

Leader, Early Myeloma Program
Director, Myeloma Tissue Bank
Tenured Associate Professor
University of Texas MD Anderson Cancer Center
Houston, Texas